Two new oral drugs — cladribine and fingolimod — are able to reduce the rates of relapses in multiple sclerosis patients, studies show.
Visit link:
New Oral MS Drugs May Be on the Horizon
{ 0 comments }
Posts tagged as:
Two new oral drugs — cladribine and fingolimod — are able to reduce the rates of relapses in multiple sclerosis patients, studies show.
Visit link:
New Oral MS Drugs May Be on the Horizon
{ 0 comments }